PT-141 in Dubai: Bremelanotide Information and Care Options
PT-141, also known as bremelanotide, is a synthetic peptide that acts on melanocortin receptors. Medilife provides PT-141 information and enquiries in Dubai, with individual suitability considered before care is arranged. Medilife has provided home healthcare in Dubai since 2016.
If you are considering PT-141, start by discussing your concerns, health history and current medicines. You may also see the name written as pt 141 or pt141.
What Medilife can provide
Medilife can help you clarify the available PT-141 options, their listed prices and the questions to discuss before proceeding.
Your enquiry should establish which product is being considered, what the appointment includes and who is responsible for your care. A product choice should follow an appropriate clinical assessment, rather than an online description of expected benefits.
[CONFIRM: exact assessment, prescribing and administration services included.]
What an individual assessment considers
An assessment considers your reason for seeking care alongside your medical history, medicines and relevant health factors. Sexual-health concerns can involve physical health, emotional wellbeing and relationship circumstances.
Be ready to explain what has changed, how long the concern has been present and whether it causes distress. Bring details of prescribed medicines, supplements and any previous assessment.
Questions about PT-141 for men
If you are researching PT-141 for men, be cautious about claims promising increased libido or improved sexual performance.
The US product information for Vyleesi, a bremelanotide medicine, does not indicate use in men or for sexual-performance enhancement. An assessment should address your specific concern before considering any product or care option. vyleesi.com
Sexual desire concerns and clinical context
Sexual desire, arousal and erectile function are different. Reduced interest in sexual activity is not the same as difficulty achieving or maintaining an erection.
Explaining the concern clearly helps a clinician identify which questions need further assessment. It also helps avoid choosing a product that does not match the reason you sought care.
PT-141 injection and other product formats
Medilife’s supplied PT-141 options include an injectable vial, injectable pens and a nasal spray. These formats require individual consideration; their shared substance name does not make them interchangeable.
The US-labeled bremelanotide medicine uses a subcutaneous route, meaning under the skin. Information about that medicine cannot automatically establish the suitability of a different formulation. dailymed.nlm.nih.gov
Ask about the exact product, its intended use and the professional guidance relevant to it. Research-labeled material and analytical purity documentation alone do not establish suitability for patient administration.
[CONFIRM: product names, formulations and administration routes used by Medilife.]
Side effects and suitability considerations
Bremelanotide can cause nausea, flushing, headache, vomiting and injection-site reactions. Other important concerns include temporary increases in blood pressure, reductions in heart rate and changes in skin pigmentation.
The US product information lists uncontrolled high blood pressure and known cardiovascular disease as contraindications. It also identifies interactions involving oral medicines, including naltrexone, and pregnancy-related precautions. dailymed.nlm.nih.gov
Tell the clinician about your cardiovascular history, all medicines and supplements, and whether you are pregnant, breastfeeding or planning pregnancy. Do not stop prescribed medicines or change your care based on information from this page.
How an at-home visit works
Before arranging a home visit, discuss the proposed care and confirm what the appointment includes. You should know which professional will attend, what screening is required and what support is available afterwards.
Screening and consent should address your health circumstances, the proposed product and relevant risks. You should have an opportunity to ask questions before agreeing to care.
[CONFIRM: Medilife’s PT-141 home-visit process, including nurse attendance, screening, consent and follow-up arrangements.]
Accessing PT-141 information and care in Dubai
Contact Medilife to discuss the product options, appointment arrangements and availability for your location.
PT-141 prices
Injectable vial
- Listed price
- AED 1,375
Injectable pen
- Listed price
- AED 1,175 or AED 1,575, depending on the product
Nasal spray
- Listed price
- AED 975
| PT-141 option | Listed price |
|---|---|
| Injectable vial | AED 1,375 |
| Injectable pen | AED 1,175 or AED 1,575, depending on the product |
| Nasal spray | AED 975 |
The pen prices refer to two different product presentations. Ask the team which presentation is being quoted and what the price includes.
Before booking, clarify whether assessment, administration, home attendance and follow-up are included or charged separately.
[CONFIRM: price basis, approved names distinguishing the pens, inclusions and any applicable VAT.]
Call +971 52 345 2646 for product and appointment details.
Rules depend on the particular product and licensed provider.
[LEGAL REVIEW NEEDED: UAE product, prescribing, supply and home-administration wording.]
For broader guidance, read Medilife’s peptide legality and safety information for the UAE.
You can also explore patient feedback about Medilife on Google and Trustpilot.
Explore related peptide information
Visit Medilife’s peptide therapy page for broader information about the cluster.
- 01
GHK-Cu
Learn moreGHK-Cu, also called copper peptide, is a distinct substance. If your enquiry concerns GHK-Cu, the GHK-Cu information page provides the relevant starting point for discussing that product separately.
- 02
CJC-1295 and Ipamorelin
Learn moreMedilife’s CJC-1295 and Ipamorelin page covers those substances together. Their inclusion in the peptide cluster is not a recommendation to combine them with PT-141 or use them for the same purpose.
Frequently asked questions
PT-141 is another name for bremelanotide, a synthetic peptide classified as a melanocortin receptor agonist. Understanding the substance is only one part of a care decision. The particular formulation, your health circumstances and the proposed service also need consideration before proceeding with any product.
Yes. Bremelanotide and PT-141 refer to the same substance. However, products carrying either name can differ in formulation, labeling and intended use. Ask about the exact product being discussed rather than assuming that a vial, pen, nasal spray and prescription medicine are equivalent.
Men should seek an assessment of their particular sexual-health concern before considering PT-141. The US bremelanotide product information does not indicate use in men or for sexual-performance enhancement. Online descriptions promising male benefits do not establish that the product is appropriate for your circumstances. vyleesi.com
Bremelanotide has been studied in premenopausal women with acquired, generalised hypoactive sexual desire disorder, involving low desire with associated distress. That specific clinical context should not be extended to every sexual-health concern. A clinician needs to assess the individual and the particular product being considered.
Reported effects include nausea, flushing, headache, vomiting and injection-site reactions. Blood-pressure changes and pigmentation changes are also relevant. Discuss your medical history and medicines before care, and ask whom to contact if symptoms occur. Your clinician should explain the risks relevant to the proposed product.
No. Different formats can have different product information, evidence and intended uses. The US-labeled bremelanotide medicine is a subcutaneous injection. Do not switch between formats or assume that an online product description provides enough information to choose an appropriate formulation for your care.
Call Medilife to discuss the listed options and the assessment or supply arrangements that apply. Product selection should follow the appropriate clinical discussion. [CONFIRM: approved wording for Medilife’s PT-141 supply pathway.] Ask what is required before a product or appointment can be arranged.
The supplied prices are AED 1,375 for the injectable vial, AED 1,175 or AED 1,575 for the two pen presentations, and AED 975 for the nasal spray. Confirm the exact product and whether assessment, administration, home attendance or follow-up carry separate charges before proceeding.
Speak with Medilife about PT-141
Medically reviewed by [CLINICIAN NAME, LICENCE]
Last reviewed [DATE]
This information is for general understanding and is not a substitute for a doctor’s assessment or individual medical advice.
Find us & get in touch
Visit Medilife Healthcare Services LLC or contact our team about the care you need.
Our location
Medilife Healthcare Services LLC
DHA-licensed healthcare provider offering 24/7 home healthcare services in Dubai. Our team is ready to deliver comprehensive medical support to your location.